Pentacarinat and Hypokalemia - a phase IV clinical study of FDA data

Summary:

Hypokalemia is reported as a side effect among people who take Pentacarinat (pentamidine isethionate), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Revlimid, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Hypokalemia when taking Pentacarinat. It is created by eHealthMe based on reports of 1,546 people who have side effects when taking Pentacarinat from the FDA, and is updated regularly.

What is Pentacarinat?

Pentacarinat has active ingredients of pentamidine isethionate. eHealthMe is studying from 1,546 Pentacarinat users. Check the latest studies of Pentacarinat.

What is Hypokalemia?

Hypokalemia (low potassium) is found to be associated with 2,086 drugs and 3,091 conditions by eHealthMe. Check the latest studies of Hypokalemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

1,546 people reported to have side effects when taking Pentacarinat.
Among them, 17 people (1.1%) have Hypokalemia.

Among these 17 people:

How long have people been on Pentacarinat when they have Hypokalemia? *

What is the gender of people who have Hypokalemia when taking Pentacarinat? *

female: 23.53 %
male: 76.47 %

What is the age of people who have Hypokalemia when taking Pentacarinat? *

What are other drugs people take besides Pentacarinat? *

What are other side effects people have besides Hypokalemia? *

Lymphopenia (an abnormally low level of lymphocytes in the blood): 8 people, 47.06%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 5 people, 29.41%
Purpura (purplish discoloration of the skin): 5 people, 29.41%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 29.41%
Diarrhea: 5 people, 29.41%
Fever: 5 people, 29.41%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 5 people, 29.41%
Rashes (redness): 5 people, 29.41%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 3 people, 17.65%
Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 2 people, 11.76%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 9 people, 52.94%
High Blood Pressure: 8 people, 47.06%
Indigestion: 7 people, 41.18%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 6 people, 35.29%
Back Pain: 5 people, 29.41%
Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 5 people, 29.41%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 5 people, 29.41%
Insomnia (sleeplessness): 5 people, 29.41%
Constipation: 5 people, 29.41%
Pain: 5 people, 29.41%

* Approximation only. Some reports may have incomplete information.

Do you take Pentacarinat and have Hypokalemia?

- Check whether Hypokalemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pentacarinat:

Pentacarinat (1,546 reports)

Hypokalemia treatments and more:

Hypokalemia (72,278 reports)

Browse all side effects of Pentacarinat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypokalemia:

Hypokalemia (2,086 drugs)

Browse all the conditions that are associated with Hypokalemia:

Hypokalemia (3,091 conditions)

Related publications that referenced our studies

Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .
Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on pentamidine isethionate (the active ingredients of Pentacarinat) and Pentacarinat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.